Cargando…

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease

OBJECTIVE: In this study, we assessed plasma biomarkers to identify cognitive impairment in Parkinson’s disease (PD) patients by applying ultra-sensitive immunomagnetic reduction-based immunoassay (IMR). METHODS: The study enrolled 60 PD patients and 28 age- and sex-matched normal controls. Complete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Nai-Ching, Chen, Hsiu-Ling, Li, Shau-Hsuan, Chang, Yen-Hsiang, Chen, Meng-Hsiang, Tsai, Nai-Wen, Yu, Chiun-Chieh, Yang, Shieh-Yueh, Lu, Cheng-Hsien, Lin, Wei-Che
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198695/ https://www.ncbi.nlm.nih.gov/pubmed/32410983 http://dx.doi.org/10.3389/fnagi.2020.00112

Ejemplares similares

Reduced gray matter volume and respiratory dysfunction in Parkinson’s disease: a voxel-based morphometry study
por: Lee, Sieh-Yang, et al.
Publicado: (2018)

Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease
por: Yu, Chiun-Chieh, et al.
Publicado: (2016)

Vascular Inflammation Is a Risk Factor Associated with Brain Atrophy and Disease Severity in Parkinson's Disease: A Case-Control Study
por: Yu, Chiun-Chieh, et al.
Publicado: (2020)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Interaction of systemic oxidative stress and mesial temporal network degeneration in Parkinson’s disease with and without cognitive impairment
por: Chiang, Pi-Ling, et al.
Publicado: (2018)

Associations among Cognitive Functions, Plasma DNA, and White Matter Integrity in Patients with Early-Onset Parkinson's Disease
por: Chen, Yueh-Sheng, et al.
Publicado: (2017)

Association Between Autonomic Impairment and Structural Deficit in Parkinson Disease
por: Chen, Meng-Hsiang, et al.
Publicado: (2016)

Brain mediators of systemic oxidative stress on perceptual impairments in Parkinson’s disease
por: Lin, Wei-Che, et al.
Publicado: (2015)

Associations among Cognitive Functions, Plasma DNA, and Diffusion Tensor Image along the Perivascular Space (DTI-ALPS) in Patients with Parkinson's Disease
por: Chen, Hsiu-Ling, et al.
Publicado: (2021)

The Potential Effects of Oxidative Stress-Related Plasma Abnormal Protein Aggregate Levels on Brain Volume and Its Neuropsychiatric Consequences in Parkinson's Disease
por: Chen, Pei-Chin, et al.
Publicado: (2021)

Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson's Disease
por: Chen, Meng-Hsiang, et al.
Publicado: (2017)

Peripheral Leukocyte Apoptosis in Patients with Parkinsonism: Correlation with Clinical Characteristics and Neuroimaging Findings
por: Lin, Wei-Che, et al.
Publicado: (2014)

Long-Term Neuropsychological Sequelae in HIV-Seronegative Cryptococcal Meningoencephalitis Patients with and without Ventriculoperitoneal Shunts: A Cine MRI Study
por: Chen, Meng-Hsiang, et al.
Publicado: (2015)

White matter damage and systemic inflammation in Parkinson’s disease
por: Chiang, Pi-Ling, et al.
Publicado: (2017)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

Associations between Brain Structural Damage and Core Muscle Loss in Patients with Parkinson’s Disease
por: Wu, Ying-Nong, et al.
Publicado: (2020)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

The corticolimbic structural covariance network as an early predictive biosignature for cognitive impairment in Parkinson's disease
por: Chen, Yueh-Sheng, et al.
Publicado: (2021)

Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease
por: Lin, Wei-Che, et al.
Publicado: (2017)

Brain Atrophy Mediates the Relationship between Misfolded Proteins Deposition and Cognitive Impairment in Parkinson’s Disease
por: Yu, Chiun-Chieh, et al.
Publicado: (2021)

Associations Between Cognitive Functions and Physical Frailty in Patients With Parkinson’s Disease
por: Lin, Wei-Che, et al.
Publicado: (2019)

Reduced Gray Matter Volume and Risk of Falls in Parkinson’s Disease with Dementia Patients: A Voxel-Based Morphometry Study
por: Cheng, Kai-Lun, et al.
Publicado: (2020)

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
por: Lin, Chin-Hsien, et al.
Publicado: (2019)

Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021)

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
por: Yang, Shieh-Yueh, et al.
Publicado: (2016)

Dopaminergic Therapy Modulates Cortical Perfusion in Parkinson Disease With and Without Dementia According to Arterial Spin Labeled Perfusion Magnetic Resonance Imaging
por: Lin, Wei-Che, et al.
Publicado: (2016)

Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
por: Chiu, Ming-Jang, et al.
Publicado: (2021)

Usefulness of Plasma YKL-40 in Management of Community-Acquired Pneumonia Severity in Patients
por: Wang, Hsiang-Ling, et al.
Publicado: (2013)

Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Integrated (18)F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
por: Li, Cheng-Hsuan, et al.
Publicado: (2021)

Diffusion Tensor Imaging Study of White Matter Damage in Chronic Meningitis
por: Lin, Wei-Che, et al.
Publicado: (2014)

Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson’s Disease
por: Chung, Chen-Chih, et al.
Publicado: (2021)

Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson’s disease
por: Ren, Jingru, et al.
Publicado: (2022)

Altered Body Composition of Psoas and Thigh Muscles in Relation to Frailty and Severity of Parkinson’s Disease
por: Wang, Cheng-Kang, et al.
Publicado: (2019)

Association between Peripheral Oxidative Stress and White Matter Damage in Acute Traumatic Brain Injury
por: Lin, Wei-Ming, et al.
Publicado: (2014)

Longitudinal brain structural alterations and systemic inflammation in obstructive sleep apnea before and after surgical treatment
por: Lin, Wei-Che, et al.
Publicado: (2016)

Correlation between Dopamine Transporter Degradation and Striatocortical Network Alteration in Parkinson’s Disease
por: Lin, Wei-Che, et al.
Publicado: (2017)

Plasma extracellular vesicle tau, β-amyloid, and α-synuclein and the progression of Parkinson’s disease: a follow-up study
por: Chan, Lung, et al.
Publicado: (2023)

Structural and cognitive deficits in chronic carbon monoxide intoxication: a voxel-based morphometry study
por: Chen, Hsiu-Ling, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i0imgl7o6totfum2vbbbs0ibbo